Company Profile

Intellego Technologies AB is a Sweden-based company engaged in photochromatic indicator technology. The Company is a manufacturer of colorimetric ultraviolet indicators. UVC Dosimeters are used in Healthcare, Hospitality, Retail, Transportation and Commercial Applications around the world. With its patented photochromic ink that changes color based on exposure to ultraviolet irradiation or specific substances, Intellego produces dosimeters in a variety of formats and custom options to meet the constantly evolving needs of Ultraviolet Device Manufacturers (OEMs) and end-users. Intellego Technologies is headquartered in Stockholm, with product development and manufacturing based in the southwest region of Sweden.

Employees

Sector

Biotechnology & Medical Research

Calendar

08-27 Earnings release - Q2 2026

More about the company

04-14	Intellego admits 2023 sales figures are also inaccurate - Di	FW
03-24	Indictment of former Intellego CEO postponed until July	FW
03-13	Board member departs Intellego - DI	FW
03-11	Mangold: Intellego shares trading at 9 kronor in grey market - Di	FW
03-10	Intellego shares trading at 1 SEK in grey market - EFN	FW
03-08	Intellego Technologies AB(OM:INT) dropped from S&P Global BMI Index	CI
03-04	Intellego to Be Delisted from Nasdaq First North (update)	FW
03-04	Intellego Technologies to be delisted from Nasdaq Stockholm	RE
03-04	Intellego to Be Delisted from Nasdaq First North	FW
03-02	Suspicions Against Möllerström Dropped in Intellego Investigation - Afv	FW
02-26	Board of Intellego Technologies resolves on staff cuts	RE
02-26	Intellego Announces Layoffs for Six Employees	FW
02-26	Intellego Technologies AB Resolves to Reduce the Permanent Workforce in Order to Strengthen the Company's Financial Position	CI

25-10-13	Intellego Short Seller Did Not Compare Results with RISE (Update)	FW
25-10-13	Intellego Board Addresses Speculation - Partnerships Proceeding as Planned	FW
25-10-09	Montega Discontinues Coverage of Intellego	FW
25-10-02	Intellego Releases Preliminary Q3 Results - EBIT Expected to Exceed SEK 130 Million	FW
25-09-22	Intellego Shares Slide After CEO Comments on Executive Departures and Margins	FW

04-07	Notice of extraordinary general meeting and first control meeting of Intellego Technologies AB (publ)	AQ
03-04	Decision on delisting from the Nasdaq First North Growth Market trading platform will be executed on 4 March 2026	AQ
03-04	The Disciplinary Committee of Nasdaq Stockholm has decided to delist the shares in Intellego Technologies AB (publ) from Nasdaq First North Growth Market	AQ
02-26	The board of directors of Intellego Technologies AB (publ) resolves on staff cuts	AQ
02-23	The board of directors of Intellego Technologies AB (publ) dismisses the CEO	AQ

12-17	Les derniers arbitrages des gérants smallcaps
25-10-14	Smalls Caps : Les derniers choix des stars de la gestion
25-09-15	Small Caps : un rattrapage à risque ?

Manager	Title	Age	Since
Simon Marshall CEO	Chief Executive Officer	-	-
Henrik Resmark DFI	Director of Finance/CFO	57	2026-02-09
Laila Ostertag CTO	Chief Tech/Sci/R&D Officer	-	2021-08-12

Intellego Technologies AB Stock

Stocks

INT

SE0016075063

Biotechnology & Medical Research

Chart: Intellego Technologies AB

Latest news : Intellego Technologies AB

Analysts' recommendations: Intellego Technologies AB

Press Releases: Intellego Technologies AB

News in other languages: Intellego Technologies AB

Quotes and Performance

Managers and Directors: Intellego Technologies AB

Latest insider transactions

Other Biotechnology & Medical Research

Company Profile

Director	Title	Age	Since
Carl Olsson CHM	Chairman	64	2026-02-22
Anders Lennart Ermén BRD	Director/Board Member	63	2026-02-22
Mats Geijer BRD	Director/Board Member	49	2026-02-22

Date	Insider	Type	Main position	Quantity	% Market Cap.
9/16/25	Claes Ian Lindahl	Buy	Chief Executive Officer	3,000	0.0101%
9/15/25	Claes Ian Lindahl	Buy	Chief Executive Officer	2,805	0.0095%
9/9/25	Claes Ian Lindahl	Buy	Chief Executive Officer	363	0.0012%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INTELLEGO TECHNOLOGIES AB	+4.96%	+13.54%	-	-	167M
LONZA GROUP AG	-1.60%	+0.86%	+3.70%	+14.41%	49.54B
REVOLUTION MEDICINES, INC.	-0.14%	+4.03%	+482.13%	+584.43%	44.06B
BEONE MEDICINES AG	-0.06%	+9.62%	+24.63%	+81.63%	40.85B
IQVIA HOLDINGS INC.	-0.87%	+2.40%	+30.01%	+9.95%	40.14B
CELLTRION, INC.	-4.04%	+6.15%	+23.03%	+48.00%	34.17B
MEDPACE HOLDINGS, INC.	-1.41%	+1.57%	+29.98%	+123.68%	16.9B
ASCENDIS PHARMA A/S	+0.35%	+4.61%	-	-	16.78B
EUROFINS SCIENTIFIC SE	-0.43%	-0.11%	+4.22%	+20.83%	14B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+0.84%	+9.07%	+86.17%	+32.60%	13.46B
Average	-0.24%	+4.74%	+85.48%	+114.44%	29.99B
Weighted average by Cap.	-1.01%	+5.04%	+103.30%	+136.92%